MINERVA trial results reported

被引：0
|
作者：
Alexandra Roberts
机构：
来源：
Nature Reviews Cardiology | 2014年 / 11卷 / 7期
关键词：
D O I：
10.1038/nrcardio.2014.68
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：372 / 372
相关论文
共 50 条
  • [1] First reboxetine trial results reported
    Magee, J
    [J]. LANCET, 1997, 350 (9070): : 36 - 36
  • [2] News from the MINERVA trial
    Taylor, Jennifer
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (05) : 260 - 260
  • [3] Recent Results from MINERvA
    Miller, J.
    [J]. NUCLEAR AND PARTICLE PHYSICS PROCEEDINGS, 2015, 265 : 201 - 204
  • [4] Antitachycardia pacing therapies reverse atrial remodeling. The results of the international randomized MINERVA trial
    Boriani, G.
    Tukkie, R.
    Biffi, M.
    Mont, L.
    Ricci, R.
    Purerfellner, H.
    Botto, G. L.
    Manolis, A. S.
    Landolina, M.
    Gulizia, M.
    Pieragnoli, P.
    Capogrosso, P.
    Pisano, E. L. C.
    Grammatico, A.
    Padeletti, L.
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 : 1304 - 1304
  • [5] Positive clinical trial results reported for HTF-919
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 1998, 11 (07) : 410 - 410
  • [6] NCI-sponsored digital mammography trial results reported
    不详
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (11): : 1398 - 1398
  • [7] Positive results of Phase II trial of Atengenal and Astugenal reported
    不详
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (01) : 7 - 7
  • [8] The effects of reactive atrial antitachycardia pacing on the progression of atrial tachyarrhythmias: secondary analysis results of the randomized MINERVA trial
    Padeletti, L.
    Mont, L.
    Purerfellner, H.
    Manolis, A.
    Tukkie, R.
    Santini, M.
    Inama, G.
    Serra, P.
    Gavazza, F.
    Boriani, G.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 358 - 358
  • [9] PACS 01 trial: Questions about patients' characteristics and reported results
    Demonty, Gaston
    Bogaerts, Jan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2143 - 2143
  • [10] Phase I/II trial results reported for Neovastat in lung cancer
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 1998, 11 (01) : 57 - 57
12345